ViqusViqus
Navigate
Company
Blog
About Us
Contact
System Status
Enter Viqus Hub

Neurable Pivots to Licensing Non-Invasive BCI Tech for Ubiquitous Wearables

Brain-Computer Interface BCI Non-invasive BCI Wearables Neural data AI Tech commercialization
April 28, 2026
Source: TechCrunch AI
Viqus Verdict Logo Viqus Verdict Logo 7
Market Scaling: BCI Moves to Ubiquitous Wearables
Media Hype 6/10
Real Impact 7/10

Article Summary

BCI technology is moving from science fiction to a commercial corner of the tech industry, highlighted by Neurable’s pivot to licensing. Neurable specializes in non-invasive BCIs, which use EEG sensors and AI processing to analyze brain activity without surgery, distinguishing itself from implantable competitors like Neuralink. Having raised $35 million in a Series A, the company announced it is seeking to license its 'mind-reading' tech to various consumer-facing companies. The goal is to embed detailed brain-sensing data into existing hardware—such as headphones, glasses, and headbands—for industries ranging from gaming and health to productivity. The company emphasizes its platform approach, allowing OEMs to integrate the AI-powered sensing technology while retaining design control. Addressing concerns about data intimacy, Neurable confirmed its commitment to robust anonymization and HIPAA standards for user data.

Key Points

  • Neurable is shifting its strategy from specific partnerships to a broad licensing model to scale its non-invasive BCI technology across many wearable Original Equipment Manufacturers (OEMs).
  • The core technology uses EEG sensors combined with AI analysis to gather detailed, non-invasive data on a user's cognitive performance and brain activity.
  • Despite the 'non-invasive' label, the company emphasizes rigorous privacy measures, including HIPAA compliance and user consent, to manage highly intimate neural data.

Why It Matters

This news represents a critical maturation point for BCI technology. By focusing on a licensing platform for non-invasive wearables, Neurable drastically lowers the barrier to entry for enterprise and consumer adoption compared to surgical implant approaches. Professionals should care because this signals the beginning of a 'ubiquitous' phase for brain-sensing tech, moving it from specialized medical trials into everyday products like headphones and smart glasses, which will fundamentally change how attention, focus, and performance metrics are measured and marketed.

You might also be interested in